Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Berbis

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Revue De L'Infirmiere|December 12, 2024
[University hospital nurse: the challenges of this new status]Sébastien Colson, Ludovic Loquet, Philippe Berbis
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 2, 2019
Glucagonoma with Paraneoplasic Dermatitis: Diagnosis and ManagementThéophile Guilbaud, Philippe Berbis, David Jérémie Birnbaum
Dermatologic Therapy|July 16, 2020
Severe dermatomyositis revealing a thymic carcinoma: Did rituximab delay the diagnosis?Mathilde Barré, Emmanuel Delaporte, Philippe Berbis, et al.
Rheumatology International|April 30, 2018
Paradoxical pustular psoriasis induced by ustekinumab in a patient with Crohn's disease-associated spondyloarthropathyMichael Benzaquen, Benoit Flachaire, Frank Rouby, et al.
Journal of the American Academy of Dermatology|July 18, 2018
Reply to: "Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?"Michael Benzaquen, Luca Borradori, Simone Cazzaniga, et al.
The Australasian Journal of Dermatology|June 30, 2017
Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumabMichael Benzaquen, Jilliana Monnier, Yasmine Beaussault, et al.
The Pediatric Infectious Disease Journal|December 29, 2007
Cutaneous leishmaniasis treated with azithromycin in a childPhilippe Minodier, Laurent Zambelli, Charles Mary, et al.
Journal of the American Academy of Dermatology|December 24, 2017
Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and SwitzerlandMichael Benzaquen, Luca Borradori, Philippe Berbis, et al.
Journal of Translational Medicine|June 25, 2016
TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapySandrine Guis, Philippe Berbis, Delphine Stephan, et al.
Joint Bone Spine|March 23, 2007
Neurofibromatosis type 1 with sciaticaCaroline Charpin, Philippe Berbis, Jérome Schmitz, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Revue De L'Infirmiere|December 12, 2024
[University hospital nurse: the challenges of this new status]Sébastien Colson, Ludovic Loquet, Philippe Berbis
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 2, 2019
Glucagonoma with Paraneoplasic Dermatitis: Diagnosis and ManagementThéophile Guilbaud, Philippe Berbis, David Jérémie Birnbaum
Dermatologic Therapy|July 16, 2020
Severe dermatomyositis revealing a thymic carcinoma: Did rituximab delay the diagnosis?Mathilde Barré, Emmanuel Delaporte, Philippe Berbis, et al.
Rheumatology International|April 30, 2018
Paradoxical pustular psoriasis induced by ustekinumab in a patient with Crohn's disease-associated spondyloarthropathyMichael Benzaquen, Benoit Flachaire, Frank Rouby, et al.
Journal of the American Academy of Dermatology|July 18, 2018
Reply to: "Bullous pemphigoid and diabetes mellitus: Are we missing the larger picture?"Michael Benzaquen, Luca Borradori, Simone Cazzaniga, et al.
The Australasian Journal of Dermatology|June 30, 2017
Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumabMichael Benzaquen, Jilliana Monnier, Yasmine Beaussault, et al.
The Pediatric Infectious Disease Journal|December 29, 2007
Cutaneous leishmaniasis treated with azithromycin in a childPhilippe Minodier, Laurent Zambelli, Charles Mary, et al.
Journal of the American Academy of Dermatology|December 24, 2017
Dipeptidyl peptidase IV inhibitors, a risk factor for bullous pemphigoid: Retrospective multicenter case-control study from France and SwitzerlandMichael Benzaquen, Luca Borradori, Philippe Berbis, et al.
Journal of Translational Medicine|June 25, 2016
TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapySandrine Guis, Philippe Berbis, Delphine Stephan, et al.
Joint Bone Spine|March 23, 2007
Neurofibromatosis type 1 with sciaticaCaroline Charpin, Philippe Berbis, Jérome Schmitz, et al.
Pageof 3